Severe aplastic anaemia is a life-threatening bone marrow failure condition that requires aggressive treatment with either stem cell transplant or immunosuppressive therapy combined with a thrombopoietin receptor agonist like Eltrombopag. For haematology units at UT Southwestern Medical Center, Baylor University Medical Center, and Texas Oncology clinics in Dallas, Rompag 50mg — generic Eltrombopag Olamine 50mg — provides a high-dose option for both aplastic anaemia and refractory chronic ITP at dramatically reduced cost.
Rompag 50mg contains Eltrombopag Olamine 50mg, used at doses up to 150mg daily in aplastic anaemia patients undergoing combination immunosuppressive therapy with horse anti-thymocyte globulin (hATG) and cyclosporine. Clinical trials demonstrated that adding Eltrombopag to standard IST produced complete haematologic responses in over 90% of previously untreated severe aplastic anaemia patients — a remarkable result for a historically difficult-to-treat condition.
For Dallas-based hospital pharmacies supplying haematology units, Rompag 50mg provides an institutional supply solution at significantly lower cost than brand Revolade. We supply with full WHO-GMP certification, certificate of analysis, and USFDA-compliant documentation for hospital formulary approval processes.
Unnati Pharmax supplies Rompag 50mg to haematology hospitals, oncology pharmacies, and patients in Dallas and across the USA. Visit medshopy.com or WhatsApp +91 82650 41513 for wholesale pricing.
